Ono Pharmaceutical Co., Ltd. (OTCMKTS: OPHLY – Get a rating) experienced significant growth in short-term interest in the month of March. As of March 31, there were short interests totaling 25,100 shares, a growth of 61.9% from the total of 15,500 shares as of March 15. Based on an average daily volume of 24,500 shares, the day-to-cover ratio is currently 1.0 day.
OTCMKTS: OPHLY traded at $0.04 during midday trading on Friday, reaching $8.46. 12,822 shares of the company were traded, against an average volume of 26,713. Ono Pharmaceutical has a one-year low of $6.89 and a one-year high of $9.43. The company’s fifty-day simple moving average is $8.32 and its two-hundred-day simple moving average is $7.86.
Ono Pharmaceutical Company Profile (Get a rating)
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases and sells pharmaceuticals and diagnostic reagents worldwide. The company offers OPDIVO intravenous infusions for the treatment of malignant tumors; KYPROLIS for intravenous injection; EMEND capsules/PROEMEND intravenous injections for chemotherapy-induced nausea and vomiting; DEMSER Capsule for improvement of symptoms in patients with pheochromocytoma; and BRAFTOVI capsules, and MEKTOVI and VELEXBRU tablets for malignant tumors.
Get news and reviews for Ono Pharmaceutical Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Ono Pharmaceutical and related companies with MarketBeat.com’s free daily email newsletter.